This is a preview of subscription content, log in via an institution to check access.
Reference
Jiang Y, et al. Cost-effectiveness and value-based prices of the 9-valent human papillomavirus vaccine for the prevention of cervical cancer in China: an economic modelling analysis. BMJ Open : 3 Dec 2019. Available from: URL: http://dx.doi.org/10.1136/bmjopen-2019-031186
Rights and permissions
About this article
Cite this article
9-valent HPV vaccine not cost effective in China. PharmacoEcon Outcomes News 843, 2 (2019). https://doi.org/10.1007/s40274-019-6429-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6429-x